Eyes and ears and nose, percutaneous approach

85812100 Category Share

Eyes and ears and nose, percutaneous approach is an EFRIS commodity class (code 85812100) under Administrative interventions or procedures, physiological systems and anatomical regions, introduction and irrigation and circulatory in Uganda Revenue Authority's e-invoicing system.

38 items in this category

• 85812116Introduction of analgesics, hypnotics, sedatives into ear, percutaneous approach
  Exempt
• 85812103Introduction of analgesics, hypnotics, sedatives into eye, percutaneous approach
  Exempt
• 85812128Introduction of analgesics, hypnotics, sedatives into nose, percutaneous approach
  Exempt
• 85812121Introduction of anti-inflammatory into ear, percutaneous approach
  Exempt
• 85812109Introduction of anti-inflammatory into eye, percutaneous approach
  Exempt
• 85812134Introduction of anti-inflammatory into nose, percutaneous approach
  Exempt
• 85812115Introduction of destructive agent into ear, percutaneous approach
  Exempt
• 85812101Introduction of destructive agent into eye, percutaneous approach
  Exempt
• 85812127Introduction of destructive agent into nose, percutaneous approach
  Exempt
• 85812126Introduction of liquid brachytherapy radioisotope into ear, percutaneous approach
  Exempt
• 85812114Introduction of liquid brachytherapy radioisotope into eye, percutaneous approach
  Exempt
• 85812120Introduction of local anesthetic into ear, percutaneous approach
  Exempt
• 85812108Introduction of local anesthetic into eye, percutaneous approach
  Exempt
• 85812132Introduction of local anesthetic into nose, percutaneous approach
  Exempt
• 85812124Introduction of monoclonal antibody into ear, percutaneous approach
  Exempt
• 85812112Introduction of monoclonal antibody into eye, percutaneous approach
  Exempt
• 85812137Introduction of monoclonal antibody into nose, percutaneous approach
  Exempt
• 85812122Introduction of other anti-infective into ear, percutaneous approach
  Exempt
• 85812110Introduction of other anti-infective into eye, percutaneous approach
  Exempt
• 85812135Introduction of other anti-infective into nose, percutaneous approach
  Exempt
• 85812125Introduction of other antineoplastic into ear, percutaneous approach
  Exempt
• 85812113Introduction of other antineoplastic into eye, percutaneous approach
  Exempt
• 85812138Introduction of other antineoplastic into nose, percutaneous approach
  Exempt
• 85812117Introduction of other diagnostic substance into ear, percutaneous approach
  Exempt
• 85812105Introduction of other diagnostic substance into eye, percutaneous approach
  Exempt
• 85812129Introduction of other diagnostic substance into nose, percutaneous approach
  Exempt
• 85812102Introduction of other gas into eye, percutaneous approach
  Exempt
• 85812119Introduction of other therapeutic substance into ear, percutaneous approach
  Exempt
• 85812107Introduction of other therapeutic substance into eye, percutaneous approach
  Exempt
• 85812131Introduction of other therapeutic substance into nose, percutaneous approach
  Exempt
• 85812123Introduction of oxazolidinones into ear, percutaneous approach
  Exempt
• 85812111Introduction of oxazolidinones into eye, percutaneous approach
  Exempt
• 85812136Introduction of oxazolidinones into nose, percutaneous approach
  Exempt
• 85812104Introduction of pigment into eye, percutaneous approach
  Exempt
• 85812118Introduction of radioactive substance into ear, percutaneous approach
  Exempt
• 85812106Introduction of radioactive substance into eye, percutaneous approach
  Exempt
• 85812130Introduction of radioactive substance into nose, percutaneous approach
  Exempt
• 85812133Introduction of serum, toxoid and vaccine into nose, percutaneous approach
  Exempt